10x Genomics: Q2 Earnings Insights

10x Genomics TXG reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

10x Genomics missed estimated earnings by 46.15%, reporting an EPS of $-0.57 versus an estimate of $-0.39.

Revenue was down $1.23 million from the same period last year.

Last quarter the company missed on EPS by $0.07 which was followed by a 3.96% drop in the share price the next day.

Here's a look at 10x Genomics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.31	-0.09	-0.20	-0.26
EPS Actual	-0.38	-0.16	-0.15	-0.10
Revenue Estimate	113.34M	148.53M	122.62M	112.85M
Revenue Actual	114.50M	143.53M	125.30M	115.84M

To track all earnings releases for 10x Genomics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar